Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome
Abstract Background Encephalitis caused by dengue virus (DENV) is considered a manifestation of severe dengue. Tanreqing injection (TRQ) is a well-known Chinese patented medicine, which has been used to treat brain-related disorders by inhibiting inflammation. Nevertheless, the effects of TRQ on DEN...
Saved in:
Main Authors: | Hefei Huang (Author), Xuemei He (Author), Lingzhu Shi (Author), Jingtao Yu (Author), Zibin Lu (Author), Huihui Cao (Author), Jinying Ou (Author), Xi Chen (Author), Lijun Yan (Author), Jiabin Yang (Author), Wei Zhao (Author), Junshan Liu (Author), Linzhong Yu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway
by: Hongling Zhou, et al.
Published: (2023) -
Pharmacokinetic study of the main components of Tanreqing capsules and Tanreqing injections in beagles by liquid chromatography-tandem mass spectrometry
by: Lili Cui, et al.
Published: (2022) -
Liang-Ge-San, a Classic Traditional Chinese Medicine Formula, Attenuates Lipopolysaccharide-Induced Acute Lung Injury Through Up-Regulating miR-21
by: Huayi Yang, et al.
Published: (2019) -
Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021) -
NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)